RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $179,083 | -5.3% | 121,002 | -15.6% | 0.00% | -100.0% |
| Q1 2023 | $189,172 | -3.1% | 143,312 | +10.1% | 0.00% | 0.0% |
| Q4 2022 | $195,168 | +550.6% | 130,112 | +411.1% | 0.00% | – |
| Q3 2022 | $30,000 | +42.9% | 25,456 | +131.4% | 0.00% | – |
| Q3 2019 | $21,000 | -83.2% | 11,000 | -75.0% | 0.00% | -100.0% |
| Q2 2018 | $125,000 | – | 44,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |